LDCT Screening Significantly Reduces Lung Cancer Mortality in Non-Smokers

Population-based lung cancer screening can reduce mortality in people who have never smoked, study shows

New evidence from a Chinese cohort presented at the European Lung Cancer Congress (ELCC) 2026 shows that one-time low-dose computed tomography (LDCT) screening can significantly reduce lung cancer mortality in a non–risk based population, including individuals with no smoking history. The findings support reconsideration of current eligibility criteria, which still rely heavily on tobacco exposure.

LDCT screening significantly reduces lung cancer mortality in non-smokers

New evidence from a Chinese cohort presented today at the European Lung Cancer Congress (ELCC) 2026 shows that onetime lowdose computed tomography (LDCT) screening can significantly reduce lung cancer mortality in a non-risk based population, including individuals with no smoking history.

Low-Dose CT Screening Reduces Lung Cancer-Specific Mortality

Data from the LUNG-CARE Project showed that non–high-risk patients experienced better survival and curative potential through early detection.